MKS Instruments (MKSI) Tops Q4 EPS by 19c; offers guidance

MKS Instruments (NASDAQ: MKSI) reported Q4 EPS of $2.15, $0.19 better than the analyst estimate of $1.96. Revenue for the quarter came in at $935 million versus the consensus estimate of $915.08 million.

GUIDANCE:

MKS Instruments sees Q1 2025 EPS of $1.40 plus or minus $0.27, versus the consensus of $1.62. MKS Instruments sees Q1 2025 revenue of $910 million plus or minus $40 million, versus the consensus of $908.2 million.

For earnings history and earnings-related data on MKS Instruments (MKSI) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Why this Wall Street strategist says the "trade is long gold"
• Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal